Trimethoprim-Associated Hyperkalemia in a Young Trauma Victim

Abstract

Get full access to this article

View all access options for this article.

References

Gupta

, Stamm

. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents, 2002; 19:554–556.

Green

, Paul

, Vidal

, Leibovici

. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev, 2007; CD005590.

Metzger

, Bonatti

, Sawyer

. Future trends in the treatment of serious gram-positive infections. Drugs Today (Barc), 2009; 45:33–45.

Zervos

. Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: Oral antimicrobial agents. Surg Infect, 2008; 9,Suppl 1:S29–S34.

Penzak

, Abate

. Stenotrophomonas (Xanthomonas) maltophilia: A multidrug-resistant nosocomial pathogen. Pharmacotherapy, 1997; 17:293–301.

Sader

, Jones

. Antimicrobial susceptibility of uncommonly isolated non-enteric gram-negative bacilli. Int J Antimicrob Agents, 2005; 25:95–109.

Jick

. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis, 1982; 4:426–428.

Lawson

, Paice

. Adverse reactions to trimethoprim-sulfamethoxazole. Rev Infect Dis, 1982; 4:429–433.

Alappan

, Buller

, Perazella

. Trimethoprim-sulfamethoxazole therapy in outpatients: Is hyperkalemia a significant problem? Am J Nephrol, 1999; 19:389–394.

10.

Alappan

, Perazella

, Buller

. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med, 1996; 124:316–320.

11.

Mori

, Kuroda

, Imamura

et al. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med, 2003; 42:665–669.

12.

Perazella

. Trimethoprim is a potassium-sparing diuretic like amiloride and causes hyperkalemia in high-risk patients. Am J Ther, 1997; 4:343–348.

13.

Perazella

. Trimethoprim-induced hyperkalaemia: Clinical data, mechanism, prevention and management. Drug Saf, 2000; 22:227–236.

14.

Perazella

, Mahnensmith

. Trimethoprim-sulfamethoxazole: Hyperkalemia is an important complication regardless of dose. Clin Nephrol, 1996; 46:187–192.

15.

Antoniou

, Gomes

, Juurlink

et al. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: A population-based study. Arch Intern Med, 2010; 170:1045–1049.

16.

Mohan

, Jaitly

, Pogue

, Cheng

. Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia. J Antimicrob Chemother, 2009; 64:850–852.

17.

Weir

, Juurlink

, Gomes

et al. Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: A nested case-control study. Clin J Am Soc Nephrol, 2010.

18.

Sanjay

, Annigeri

, Gopalakrishnan

. Refractory hyperkalaemia due to trimethoprim, successfully treated with fludrocortisone. J Assoc Physicians India, 2007; 55:74–75.